Block listing Interim Review

Summary by AI BETAClose X

Spire Healthcare Group PLC reports on their block listing for the Long Term Incentive Plan. As of September 29, 2025, the balance of unallotted securities under the scheme remains at 6,911,646. During the period from March 30, 2025, to September 29, 2025, there was no increase to the block scheme, and no securities were issued or allotted. Therefore, the balance under the scheme not yet issued or allotted at the end of the period is 6,911,646.

Disclaimer*

Spire Healthcare Group PLC
30 September 2025
 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

(Note: Italicised terms have the same meaning as given in the Listing Rules.)

Date: 30 September 2025

 

Name of applicant:

Spire Healthcare Group plc

Name of scheme:

Long Term Incentive Plan

Period of return:

From:

30 March 2025

To:

29 September 2025

Balance of unallotted securities under scheme(s) from previous return:

6,911,646

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

6,911,646

 

Name of contact:

Mantraraj Budhdev, Group General Counsel and Company Secretary

Telephone number of contact:

07787 283848

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings